Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Oral Laquinimod May Reduce Destructive Pathology in RRMS
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Papers: 31 Oct 2015 - 7 Nov 2015
Papers: 18 Oct 2013 - 25 Oct 2013
Papers: 20 Dec 2014 - 27 Dec 2014
Papers: 27 Mar 2015 - 3 Apr 2015
MS Patient, Ph.D.: Neuroradiology Reader Roulette
Letter to the Editor: Trigeminal neuralgia in patients with multiple sclerosis.
Papers: 18 Jul 2014 - 25 Jul 2014
Papers: 5 Sep 2014 - 12 Sep 2014
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
Papers: 28 Nov 2015 - 5 Dec 2015
Papers: 16 May 2014 - 23 May 2014
MS Patient, Ph.D.: Pros and Cons of the First Generic DMT
Papers: 25 Feb 2013 - 4 Mar 2013
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study.
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
Debate: Do Physicians Rate the Risk of Disabling MS Less Than the Risk of Effective Treatment?
MS Research Roundup: February 2, 2015
MRI in multiple sclerosis: what's inside the toolbox?
Papers: 29 May 2015 - 5 Jun 2015
Papers: 5 Mar 2016 - 12 Mar 2016
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »
